<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30151" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thyroid Storm</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pokhrel</surname>
            <given-names>Binod</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aiman</surname>
            <given-names>Wajeeha</given-names>
          </name>
          <aff>University of Health Sciences, Lahore Pakistan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhusal</surname>
            <given-names>Kamal</given-names>
          </name>
          <aff>Louisiana State University HSC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Binod Pokhrel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wajeeha Aiman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kamal Bhusal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30151.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A thyroid storm, also known as a thyrotoxic crisis, is an acute, life-threatening complication of hyperthyroidism that presents with multi-system involvement. Despite modern advancements in its treatment and supportive measures, the mortality associated with thyroid storm is estimated to be 8 to 25%. Thus, it is very important to recognize it early and start aggressive treatment to reduce mortality. This activity reviews the tools available to assist with the diagnosis and management of thyroid storms and highlights the role of the interprofessional team in caring for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine the etiology of a thyroid storm.</p></list-item><list-item><p>Assess&#x000a0;the potential complications of a thyroid storm.</p></list-item><list-item><p>Evaluate&#x000a0;available treatment options for a thyroid storm.</p></list-item><list-item><p>Communicate&#x000a0;the importance of a well-coordinated, interprofessional team approach when managing patients presenting with thyroid storm.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30151&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30151">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30151.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Thyroid storm, also known as thyrotoxic crisis, is an acute, life-threatening complication of hyperthyroidism. It is an exaggerated presentation of thyrotoxicosis, and it comes with sudden multisystem involvement. The mortality associated with thyroid storm is estimated to be 8&#x000a0;to 25% despite modern advancements in its treatment and supportive measures.<xref ref-type="bibr" rid="article-30151.r1">[1]</xref>&#x000a0;Thus, it is very important to recognize it early and start aggressive treatment to reduce mortality. The diagnosis of thyroid storm is clinical.</p>
      </sec>
      <sec id="article-30151.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Superimposed precipitating factors cause thyroid storms in patients with diagnosed or undiagnosed hyperthyroidism. It is more common with Graves disease but can occur with other etiologies of hyperthyroidism, such as toxic multinodular goiter and toxic thyroid adenoma.<xref ref-type="bibr" rid="article-30151.r2">[2]</xref>&#x000a0;The precipitating factors are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abrupt discontinuation of antithyroid medicine</p>
          </list-item>
          <list-item>
            <p>Thyroid surgery</p>
          </list-item>
          <list-item>
            <p>Non-thyroid surgery</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Acute illnesses like infections, including COVID-19, diabetic ketoacidosis, acute myocardial infarction, cardiovascular accident, cardiac failure, and drug reactions<xref ref-type="bibr" rid="article-30151.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Parturition</p>
          </list-item>
          <list-item>
            <p>Recent use of Iodinated contrast medium</p>
          </list-item>
          <list-item>
            <p>Radioiodine therapy (rare)</p>
          </list-item>
          <list-item>
            <p>Burns</p>
          </list-item>
          <list-item>
            <p>Stroke or traumatic brain injury<xref ref-type="bibr" rid="article-30151.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Medication side effects, eg, amiodarone, anesthetics, salicylates<xref ref-type="bibr" rid="article-30151.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Hyperemesis gravidarum in pregnancy<xref ref-type="bibr" rid="article-30151.r6">[6]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is a rare presentation of hyperthyroidism. Thyroid storm accounts for about 1% to 2% of admissions for hyperthyroidism. As per the United States survey, the incidence of storms ranged from 0.57 to 0.76 cases per 100,000 per year in the normal population and 4.8 to 5.6 cases per 100,000 per year in hospitalized patients.<xref ref-type="bibr" rid="article-30151.r7">[7]</xref>&#x000a0;</p>
        <p>Per the Japanese National Survey, the incidence of thyroid storms was 0.2 per 100,000 people per year, about 0.22% of all thyrotoxicosis patients and 5.4% of hospitalized thyrotoxicosis patients. The average age of people with thyroid storm was 42 to 43 years, similar to those with thyrotoxicosis without thyroid storm. The male-to-female ratio for the incidence of thyroid storms was about 1:3, similar to that of thyrotoxicosis without storm groups.<xref ref-type="bibr" rid="article-30151.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30151.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiological basis for the precipitation of thyroid storms in patients with thyrotoxicosis is unclear. But, as mentioned above, a precipitating factor is always required to cause a thyroid storm. Several hypotheses have been proposed. One theory suggests the incidence of thyroid storm is due to the rapid increase in thyroid hormone levels rather than the absolute hormone level that occurs during thyroid surgery, following radioactive iodine treatment, after sudden discontinuation of the antithyroid drug, or after administration of the large dose of iodine in contrast studies. The hyperactivity of the sympathetic nervous system with increased response to catecholamine and an increased cellular response to thyroid hormone during acute stress or infections, causing cytokines release and altered immunological disturbances, are other possible mechanisms of thyroid storm. Most studies have failed to relate higher thyroid hormone levels as a cause of thyroid storm, except for the study by Brooks&#x000a0;and others, which reported higher free thyroid hormone among the patients with thyroid storm.<xref ref-type="bibr" rid="article-30151.r9">[9]</xref> In other words, the degree of thyroid hormone level is not directly related to a higher incidence of thyroid storm.<xref ref-type="bibr" rid="article-30151.r2">[2]</xref></p>
        <p>The clinical features are due to the exaggerated effects of the thyroid hormone. There is an intense metabolic activity that increases oxygen requirements. The resulting tachycardia to meet the oxygen requirements can induce heart failure and predispose the patient to arrhythmias. Similarly, CNS symptoms include irritability, seizures, delirium, and eventually coma.</p>
      </sec>
      <sec id="article-30151.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathology depends on the cause of the thyroid storm. The most common cause of Graves disease is&#x000a0;diffuse follicular hyperplasia, along with increased thyroid receptor antibodies and increased vascularization of the tissue. If it is a tumor-originated&#x000a0;storm, malignant cells infiltrate and destroy the thyroid tissue and rupture the follicles.<xref ref-type="bibr" rid="article-30151.r10">[10]</xref><xref ref-type="bibr" rid="article-30151.r11">[11]</xref></p>
      </sec>
      <sec id="article-30151.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Toxicokinetics includes&#x000a0;the following precipitating factors:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe emotional distress</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Exercise</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Presentation of thyroid storm is an exaggerated manifestation of hyperthyroidism, with the presence of an acute precipitating factor. Fever, cardiovascular involvement (including tachycardia, heart failure, arrhythmia), central nervous system (CNS)&#x000a0;manifestations, and gastrointestinal symptoms are common. Fever of 104&#x000b0; F to 106&#x000b0;F with diaphoresis is a key presenting feature. Cardiovascular manifestations include tachycardia of more than 140 HR/minute, heart failure with pulmonary and peripheral edema, hypotension, arrhythmia, and death from cardiac arrest. CNS involvement includes agitation, delirium, anxiety, psychosis, or coma. Gastrointestinal (GI) symptoms include nausea, vomiting, diarrhea, abdominal pain, intestinal obstruction, and acute hepatic failure.<xref ref-type="bibr" rid="article-30151.r12">[12]</xref> A Japanese study found CNS involvement to be a poor prognostic factor for increased mortality.<xref ref-type="bibr" rid="article-30151.r8">[8]</xref>&#x000a0;Physical examination findings may include high temperature, tachycardia, orbitopathy, goiter, hand tremors, moist and warm skin, hyperreflexia, systolic hypertension, and jaundice.</p>
      </sec>
      <sec id="article-30151.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of thyroid storm needs clinical suspicion based on the presentation mentioned above in a patient with hyperthyroidism or suspected hyperthyroidism. One should not wait for lab results before starting treatment. Thyroid function tests can be obtained, which usually show high FT4/FT3 and low TSH. It is not necessary to have a very&#x000a0;high level of thyroid hormone to cause a thyroid storm. Other lab abnormalities may include hypercalcemia, hyperglycemia (due to inhibition of insulin release and increased glycogenolysis), abnormal LFTs, and high or low white blood cell (WBC) count.</p>
        <p>
<bold>Burch-Wartofsky Point Scale (BWPS)</bold>
<xref ref-type="bibr" rid="article-30151.r2">[2]</xref>
</p>
        <p>In 1993, the following&#x000a0;scoring system for the diagnosis of thyroid storm was&#x000a0;introduced:</p>
        <list list-type="bullet">
          <list-item>
            <p>Temperature: 5 points per 1 F above 99 F&#x000a0;(maximum 30 points)</p>
          </list-item>
          <list-item>
            <p>CNS dysfunction: 10 points for mild (agitation), 20 for moderate (delirium, psychosis, or extreme lethargy), and 30 for severe (seizure or coma)</p>
          </list-item>
          <list-item>
            <p>Tachycardia: 5 (99-109), 10 (110 -119), 15 (120 -129), 20 (130 -139) and 25 (greater than 140)</p>
          </list-item>
          <list-item>
            <p>Presence of atrial fibrillation:10</p>
          </list-item>
          <list-item>
            <p>Heart failure: 5 for mild (pedal edema), 10 for moderate (bi-basilar rales), 15 for severe (pulmonary edema)</p>
          </list-item>
          <list-item>
            <p>GI dysfunction: 10 for moderate (diarrhea, nausea/vomiting, or abdominal pain) and 20 for severe (unexplained jaundice)</p>
          </list-item>
          <list-item>
            <p>Presence of Precipitating factor: 10 points&#x000a0;</p>
          </list-item>
        </list>
        <p>Diagnosis: A score of more than 45 highly suggests thyroid storm, 25 to 44 supports the diagnosis, and less than 25 makes the diagnosis unlikely.</p>
        <p><bold>The Japanese Thyroid Association (JTA)</bold>&#x000a0;</p>
        <p>This is a different scoring system based on similar clinical findings.<xref ref-type="bibr" rid="article-30151.r8">[8]</xref> Thyrotoxicosis (elevated FT3 and/or FT4) is a prerequisite, and it requires various combinations of the following symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>CNS manifestation (restlessness, delirium, psychosis/mental aberration, lethargy/somnolence, coma)</p>
          </list-item>
          <list-item>
            <p>Fever (38 C/100.4 F or greater)</p>
          </list-item>
          <list-item>
            <p>Tachycardia (130/min or higher)</p>
          </list-item>
          <list-item>
            <p>CHF (pulmonary edema, rales, cardiogenic shock, or NYHA class IV)</p>
          </list-item>
          <list-item>
            <p>GI/Hepatic Manifestation (Nausea, vomiting, diarrhea, total Bilirubin 3 mg/dl or more</p>
          </list-item>
        </list>
        <p>
<bold>Diagnosis</bold>
</p>
        <p>Definite Thyroid Storm (TS1): Thyrotoxicosis (elevated FT3 and/or FT4) plus</p>
        <list list-type="bullet">
          <list-item>
            <p>At least&#x000a0;1 CNS manifestation plus&#x000a0;1 or more other symptoms (fever, tachycardia, CHF, GI/Hepatic) &#x02018;OR&#x02019; A combination of at least&#x000a0;3 features among fever, GI/Hepatic, CHF, or tachycardia</p>
          </list-item>
        </list>
        <p>Suspected Thyroid Storm (TS2): Thyrotoxicosis (elevated FT3 and/or FT4) plus</p>
        <list list-type="bullet">
          <list-item>
            <p>A combination of at least&#x000a0;2 features among tachycardia, CHF, GI/Hepatic, Fever &#x02018;OR&#x02019; A patient with h/o thyroid disease, presence of goiter and exophthalmos who meets criteria for TS1 but TFTs not available&#x000a0;</p>
          </list-item>
        </list>
        <p>These scoring systems are just guidelines. The actual diagnosis is based on clinical judgment. Based on the BWPS scoring system, a score of 45 or more is more sensitive but less specific than JTA scoring systems TS1 or TS2 to detect thyroid storm cases. A BWPS score of 25 to 45 may suggest an impending storm. A chest X-ray may&#x000a0;help assess heart failure, and a head CT may help exclude a neurological cause in some patients. An ECG is often done to monitor for arrhythmias.</p>
      </sec>
      <sec id="article-30151.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of thyroid storm consists of supportive measures like intravenous (IV) fluids, oxygen, cooling blankets, acetaminophen, and specific measures to treat hyperthyroidism. If any precipitating factors, for example, infection, are present, that needs to be addressed. Patients with thyroid storm must be admitted to the intensive care unit with close cardiac monitoring and ventilatory support if needed.<xref ref-type="bibr" rid="article-30151.r1">[1]</xref><xref ref-type="bibr" rid="article-30151.r13">[13]</xref></p>
        <p>
<bold>Specific Strategic Steps for Treatment</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Therapy to control increased adrenergic tone: Beta-blocker</p>
          </list-item>
          <list-item>
            <p>Therapy to reduce thyroid hormone synthesis: Thionamide</p>
          </list-item>
          <list-item>
            <p>Therapy to reduce the release of thyroid hormone: Iodine solution</p>
          </list-item>
          <list-item>
            <p>Therapy to block peripheral conversion of T4 to T3: Iodinated radiocontrast agent, glucocorticoid, PTU, propranolol</p>
          </list-item>
          <list-item>
            <p>Therapy to reduce enterohepatic recycling of thyroid hormone: Bile acid sequestrant</p>
          </list-item>
        </list>
        <p>After&#x000a0;initial&#x000a0;supportive measures, a&#x000a0;beta-blocker should be started for any case of a suspected thyroid storm. Typically, propranolol 40 mg to 80 mg is given every 4 to 6 hours. Then, a loading dose of propylthiouracil (PTU) 500 mg to 1000 mg followed by 250 mg every 4 hours or Methimazole (MMI) 20 mg every 4 to 6 hours should be given. Propylthiouracil&#x000a0;is favored because it has a small additional effect blocking the peripheral conversion of T4 to T3. An hour after administering&#x000a0;propylthiouracil&#x000a0;or&#x000a0;methimazole, give&#x000a0;5 drops of SSKI (supersaturated potassium iodide) by mouth every 6 hours. Always administer thionamide before starting iodine solution (SSKI) therapy.<xref ref-type="bibr" rid="article-30151.r14">[14]</xref><xref ref-type="bibr" rid="article-30151.r15">[15]</xref><xref ref-type="bibr" rid="article-30151.r16">[16]</xref>&#x000a0;This prevents the imminent increase in thyroid hormone synthesis due to increased iodine load from&#x000a0;super saturated potassium iodide. Hydrocortisone 100 mg IV every&#x000a0;8 hours (or dexamethasone 2 mg every 6 hours) should also be started. Oral cholestyramine 4 grams 4 times daily can be started for severe cases if available. One should look for precipitating factors and treat them accordingly. Aspirin should be avoided due to its potential risk of increasing free thyroid hormone levels by interfering with thyroid-binding protein.</p>
        <p>In the first 24 hours of treatment,&#x000a0;propylthiouracil&#x000a0;decreases the T3 level by 45%, but methimazole&#x000a0;drops the T3 level by only 10&#x000a0;% to 15%. Methimazole causes more rapid normalization of serum T3 levels after a few weeks of treatment, and it has less hepatotoxicity compared to&#x000a0;propylthiouracil. Therefore, after initial stabilization, we should treat with&#x000a0;methimazole, and if&#x000a0;propylthiouracil&#x000a0;was started at the beginning, it should be changed to&#x000a0;methimazole later. For patients who cannot take oral antithyroid medicine, liquid preparation (pharmacist may have to compound) can be given as enemas. Sometimes, pharmacists can prepare an IV form of antithyroid medicine by dissolving the tablet.<xref ref-type="bibr" rid="article-30151.r17">[17]</xref><xref ref-type="bibr" rid="article-30151.r18">[18]</xref><xref ref-type="bibr" rid="article-30151.r19">[19]</xref></p>
        <p>Esmolol, a short-acting beta-blocker, can be given in an ICU setting at a loading dose of 250 mcg/kg to 500 mcg/kg followed by 50 mcg/kg to -100 mcg/kg/minute. Cardiovascular beta-blockers like atenolol or metoprolol should be chosen for patients with reactive airway disease. If there is a contraindication for using beta-blockers, diltiazem is an alternative. If thionamide therapy is contraindicated because of an allergic reaction, thyroidectomy is needed after treatment with a beta-blocker, hydrocortisone, cholestyramine, and iodine solution. Plasmapheresis is the last resort if all other measures fail.</p>
        <p>Once patients&#x02019; clinical conditions improve, the iodine solution should be stopped, glucocorticoids can be tapered and stopped, and beta-blockers should be adjusted. Thionamide therapy should be titrated, and if&#x000a0;propylthiouracil&#x000a0;is used initially, it should be switched to&#x000a0;methimazole. Patients should be recommended for definitive treatment with radioiodine (RAI) therapy or thyroidectomy. Surgery may be required in patients with Graves disease to treat hyperthyroidism. These patients must be pretreated with beta-blockers, glucocorticoids, and iodine formulas. Surgery is usually done after 5&#x000a0;to 7 days. As recently reported, therapeutic plasma exchange is potentially helpful in resistant cases that do not respond to conventional treatments.<xref ref-type="bibr" rid="article-30151.r20">[20]</xref><xref ref-type="bibr" rid="article-30151.r17">[17]</xref></p>
      </sec>
      <sec id="article-30151.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Thyroid storm should be differentiated from other diseases with similar symptoms and signs.<xref ref-type="bibr" rid="article-30151.r21">[21]</xref>&#x000a0;Fever is the most common presentation of multiple conditions; therefore, it can be misdiagnosed. The differential diagnoses include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Psychosis</p>
          </list-item>
          <list-item>
            <p>Cocaine use</p>
          </list-item>
          <list-item>
            <p>Pheochromocytoma</p>
          </list-item>
          <list-item>
            <p>Neuroleptic malignant syndrome</p>
          </list-item>
          <list-item>
            <p>Hyperthermia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s12" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>If toxic adenoma or multinodular goiter is causing this disease, then surgical resection and radioactive iodine ablation are the mainstays of treatment. Thyroidectomy is preferred if a patient has compressive symptoms. Patients who refuse ablation or have contraindications to surgery can be treated with long-term antithyroid medicines.<xref ref-type="bibr" rid="article-30151.r22">[22]</xref>&#x000a0;Grave's disease with intrathoracic mass causes severe compressive symptoms, and thyroidectomy is preferred in these cases. Thyroidectomy has other adverse effects, like recurrent laryngeal nerve damage and hypoparathyroidism.<xref ref-type="bibr" rid="article-30151.r23">[23]</xref><xref ref-type="bibr" rid="article-30151.r24">[24]</xref></p>
      </sec>
      <sec id="article-30151.s13" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>Radioiodine-131 (I) therapy is helpful in hyperfunctioning nodules, but the risk of hypothyroidism is 60% after a 20-year follow-up in a retrospective study.<xref ref-type="bibr" rid="article-30151.r25">[25]</xref> Other factors increasing the risk of hypothyroidism in these patients are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Methimazole therapy</p>
          </list-item>
          <list-item>
            <p>Age</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s14" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Randomized trials are still being processed to determine the efficacy and safety of more medicines.<xref ref-type="bibr" rid="article-30151.r24">[24]</xref></p>
      </sec>
      <sec id="article-30151.s15" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Complete surgical resection of the thyroid and radioiodine ablation can cause hypothyroidism. So, these patients need lifetime exogenous thyroxine therapy and should be monitored for hyperthyroidism. Dose adjustments by endocrinologists are crucial as the patient is at risk of both hypothyroidism and hyperthyroidism.<xref ref-type="bibr" rid="article-30151.r26">[26]</xref>&#x000a0;Antithyroid drugs, MMI, and PTU cause agranulocytosis. Patients on these drugs should be monitored with CBC, especially white cell count. If the white cell count starts decreasing, these drugs should be discontinued due to the increased risk of infection.<xref ref-type="bibr" rid="article-30151.r27">[27]</xref>&#x000a0;Other toxicities can cause hepatic failure, cholestasis, rash, gastrointestinal toxicity, and musculoskeletal pains.<xref ref-type="bibr" rid="article-30151.r28">[28]</xref><xref ref-type="bibr" rid="article-30151.r29">[29]</xref></p>
      </sec>
      <sec id="article-30151.s16" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>A thyroid storm is a&#x000a0;true medical emergency that is fatal if left untreated. The cause of death may be heart failure, arrhythmias, or multiple organ failure. However, with treatment, most patients see an improvement within 24 hours. Risk factors for poor prognosis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Advanced age</p>
          </list-item>
          <list-item>
            <p>Neurological deficits on admission<xref ref-type="bibr" rid="article-30151.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Failure to use beta-blockers and antithyroid medications</p>
          </list-item>
          <list-item>
            <p>Need for dialysis and/or mechanical ventilation</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s17" sec-type="Complications">
        <title>Complications</title>
        <p>If left untreated, thyroid storm can lead to the following complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>High-output cardiac failure</p>
          </list-item>
          <list-item>
            <p>Seizures, delirium, coma</p>
          </list-item>
          <list-item>
            <p>Elevated liver enzymes, jaundice</p>
          </list-item>
          <list-item>
            <p>Abdominal cramps, vomiting, diarrhea</p>
          </list-item>
          <list-item>
            <p>Atrial fibrillation and thromboembolism<xref ref-type="bibr" rid="article-30151.r30">[30]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s18" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with hyperthyroidism should be educated about the warning symptoms of thyroid storm, a serious but rare emergency. It is a dangerous disease, but early diagnosis and prompt treatment can improve the condition.&#x000a0;Hyperthyroid patients should not delay visiting the emergency department after experiencing any symptoms. After the first crisis, non-compliant behaviors should be addressed, and treatment benefits and complications should be described.<xref ref-type="bibr" rid="article-30151.r31">[31]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30151.s19" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>There are multiple factors responsible for delayed diagnosis and treatment of this emergency condition:</p>
        <list list-type="bullet">
          <list-item>
            <p>Unavailability of skilled thyroid surgeons</p>
          </list-item>
          <list-item>
            <p>Lack of suitable nuclear medicine units</p>
          </list-item>
          <list-item>
            <p>Lack of patient education</p>
          </list-item>
          <list-item>
            <p>Lack of internal physician communication</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30151.s20" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A thyroid storm is a rare, life-threatening&#x000a0;medical emergency that is difficult to diagnose. Thus, an interprofessional healthcare team that includes an intensivist, cardiologist, endocrinologist, internist, emergency department physician, and infectious disease expert is recommended. These patients are best managed in the ICU and monitored by ICU nurses. Nurses must be fully aware of the potential complications and notify the physician if there is any change in the hemodynamic status. Pharmacists can also weigh in to see if the patient takes thyrotoxic medications. The situation requires open communication channels between all professionals to bring about the best possible outcome.</p>
        <p>Treating thyroid storms involves supportive measures like intravenous (IV) fluids, oxygen, cooling blankets, acetaminophen, and specific measures to treat hyperthyroidism. If any precipitating factors, for example, an infection, are present, they must be taken care&#x000a0;of first. Patients with thyroid storm must be admitted to the intensive care unit with close cardiac monitoring and ventilatory support as needed.<xref ref-type="bibr" rid="article-30151.r1">[1]</xref><xref ref-type="bibr" rid="article-30151.r13">[13]</xref>&#x000a0;</p>
        <p>The pharmacist may need to prepare a special formula of iodine that can be administered intravenously. Radiocontrast dyes may help some patients. In some cases, plasmapheresis may be life-saving. The nephrologist/hematologist must be involved early in caring for these patients and anticipate plasmapheresis needs. The team must communicate to avoid the high mortality of thyroid storms. The outlook for patients with thyroid storm is guarded. It depends on the patient's age, the number of organs involved, comorbidities, need for mechanical ventilation, renal failure, and response to treatment.<xref ref-type="bibr" rid="article-30151.r32">[32]</xref><xref ref-type="bibr" rid="article-30151.r33">[33]</xref></p>
      </sec>
      <sec id="article-30151.s21">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30151&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30151">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/thyroid-storm/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30151">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30151/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30151">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30151.s22">
        <title>References</title>
        <ref id="article-30151.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Burch</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Greenlee</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Laurberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maia</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Rivkees</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Samuels</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Stan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.</article-title>
            <source>Thyroid</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <fpage>1343</fpage>
            <page-range>1343-1421</page-range>
            <pub-id pub-id-type="pmid">27521067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burch</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Wartofsky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Life-threatening thyrotoxicosis. Thyroid storm.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>263</fpage>
            <page-range>263-77</page-range>
            <pub-id pub-id-type="pmid">8325286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Shakti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Akam-Venkata</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Obi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Weiland</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Moskowitz</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>SARS-CoV-2 infection induced thyroid storm and heart failure in an adolescent girl.</article-title>
            <source>Cardiol Young</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>988</fpage>
            <page-range>988-992</page-range>
            <pub-id pub-id-type="pmid">34657643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Cerebral venous sinus thrombosis caused by traumatic brain injury complicating thyroid storm: a case report and discussion.</article-title>
            <source>BMC Neurol</source>
            <year>2022</year>
            <month>Jul</month>
            <day>07</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>248</fpage>
            <pub-id pub-id-type="pmid">35794521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raza</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mumtaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mehmood</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Thyroid Storm in a Patient on Chronic Amiodarone Treatment.</article-title>
            <source>Cureus</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>e24164</fpage>
            <pub-id pub-id-type="pmid">35586348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmerman</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Ilstad-Minnihan</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Bruggeman</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Bruggeman</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dayton</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Moas</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Rohrs</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Thyroid Storm Caused by Hyperemesis Gravidarum.</article-title>
            <source>AACE Clin Case Rep</source>
            <year>2022</year>
            <season>May-Jun</season>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>124</fpage>
            <page-range>124-127</page-range>
            <pub-id pub-id-type="pmid">35602873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galindo</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hurtado</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Pasquel</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Tome</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004-2013.</article-title>
            <source>Thyroid</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-43</page-range>
            <pub-id pub-id-type="pmid">30382003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akamizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Satoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Isozaki</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wakino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iburi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuboi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Monden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kouki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Teramukai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uehara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <collab>Japan Thyroid Association</collab>
            </person-group>
            <article-title>Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys.</article-title>
            <source>Thyroid</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>7</issue>
            <fpage>661</fpage>
            <page-range>661-79</page-range>
            <pub-id pub-id-type="pmid">22690898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooks</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Waldstein</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Free thyroxine concentrations in thyroid storm.</article-title>
            <source>Ann Intern Med</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>694</fpage>
            <page-range>694-7</page-range>
            <pub-id pub-id-type="pmid">7212477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Ridder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sermeus</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Urbain</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Storme</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Metastases to the thyroid gland-a report of six cases.</article-title>
            <source>Eur J Intern Med</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>377</fpage>
            <page-range>377-379</page-range>
            <pub-id pub-id-type="pmid">14769497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimaoka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>VanHerle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dindogru</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxicosis secondary to involvement of the thyroid with malignant lymphoma.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1976</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-8</page-range>
            <pub-id pub-id-type="pmid">59731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angell</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Lechner</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Salvato</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Nicoloff</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>LoPresti</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>451</fpage>
            <page-range>451-9</page-range>
            <pub-id pub-id-type="pmid">25343237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarlis</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Gourgiotis</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Thyroid emergencies.</article-title>
            <source>Rev Endocr Metab Disord</source>
            <year>2003</year>
            <month>May</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-36</page-range>
            <pub-id pub-id-type="pmid">12766540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neiva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Thyroid storm and myxoedema: two reversible causes of acute heart failure.</article-title>
            <source>Acute Med</source>
            <year>2018</year>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>229</fpage>
            <page-range>229-231</page-range>
            <pub-id pub-id-type="pmid">30882107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodier</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Endocrine Emergencies in Obstetrics.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>339</fpage>
            <page-range>339-346</page-range>
            <pub-id pub-id-type="pmid">30882392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Management of Endocrine Emergencies in the ICU.</article-title>
            <source>J Pharm Pract</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>314</fpage>
            <page-range>314-326</page-range>
            <pub-id pub-id-type="pmid">30852927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ba</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>BQ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>YF</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic plasma exchange and continuous renal replacement therapy for severe hyperthyroidism and multi-organ failure: A case report.</article-title>
            <source>World J Clin Cases</source>
            <year>2019</year>
            <month>Feb</month>
            <day>26</day>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>500</fpage>
            <page-range>500-507</page-range>
            <pub-id pub-id-type="pmid">30842962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalpakam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dhooria</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>A rare complication of bedside tracheotomy: Thyroid crisis.</article-title>
            <source>Lung India</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-79</page-range>
            <pub-id pub-id-type="pmid">30604713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrade Luz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Catorze</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Thyroid storm: a case of haemodynamic failure promptly reversed by aggressive medical therapy with antithyroid agents and steroid pulse.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Dec</month>
            <day>14</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30567262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>AWK</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>BSP</given-names>
              </name>
              <name>
                <surname>Hoe</surname>
                <given-names>JKM</given-names>
              </name>
              <name>
                <surname>Hoi</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Leow</surname>
                <given-names>MKS</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic plasma exchange for control of thyroid storm.</article-title>
            <source>J Clin Apher</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>189</fpage>
            <page-range>189-195</page-range>
            <pub-id pub-id-type="pmid">32823374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Idrose</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Acute and emergency care for thyrotoxicosis and thyroid storm.</article-title>
            <source>Acute Med Surg</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>147</fpage>
            <page-range>147-157</page-range>
            <pub-id pub-id-type="pmid">29123713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vidal-Trecan</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Eckman</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis.</article-title>
            <source>Thyroid</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>11</issue>
            <fpage>933</fpage>
            <page-range>933-45</page-range>
            <pub-id pub-id-type="pmid">15671772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Randolph</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Grillo</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Mathisen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Katlic</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kamani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zurakowski</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The surgical management of goiter: Part II. Surgical treatment and results.</article-title>
            <source>Laryngoscope</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>121</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-76</page-range>
            <pub-id pub-id-type="pmid">21154775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cramon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bjorner</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Bonnema</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Feldt-Rasmussen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gluud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gram</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Heged&#x000fc;s</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Knudsen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bach-Mortensen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nols&#x000f8;e</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nygaard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pociot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Skoog</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winkel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.</article-title>
            <source>Trials</source>
            <year>2013</year>
            <month>Apr</month>
            <day>30</day>
            <volume>14</volume>
            <fpage>119</fpage>
            <pub-id pub-id-type="pmid">23782950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ceccarelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bencivelli</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vitti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grasso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pinchera</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>331</fpage>
            <page-range>331-5</page-range>
            <pub-id pub-id-type="pmid">15730415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartalena</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of Graves disease: a global overview.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>724</fpage>
            <page-range>724-34</page-range>
            <pub-id pub-id-type="pmid">24126481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A review of treatment options for Graves' disease: why total thyroidectomy is a viable option in selected patients.</article-title>
            <source>J Community Hosp Intern Med Perspect</source>
            <year>2016</year>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>32369</fpage>
            <pub-id pub-id-type="pmid">27609732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noh</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyauchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamada</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>2157</fpage>
            <page-range>2157-62</page-range>
            <pub-id pub-id-type="pmid">17389704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>619</fpage>
            <page-range>619-29</page-range>
            <pub-id pub-id-type="pmid">25279406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cozma</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Thromboembolic complications of thyroid storm.</article-title>
            <source>Endocrinol Diabetes Metab Case Rep</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>130060</fpage>
            <pub-id pub-id-type="pmid">24683480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitzweg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reincke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000e4;rtner</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Thyroid emergencies : Thyroid storm and myxedema coma].</article-title>
            <source>Internist (Berl)</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>58</volume>
            <issue>10</issue>
            <fpage>1011</fpage>
            <page-range>1011-1019</page-range>
            <pub-id pub-id-type="pmid">28939923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyble</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Weathering the storm: A case of thyroid storm refractory to conventional treatment benefiting from therapeutic plasma exchange.</article-title>
            <source>J Clin Apher</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>678</fpage>
            <page-range>678-681</page-range>
            <pub-id pub-id-type="pmid">30321468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30151.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simsir</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erdogan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Donmez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ozgen</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic plasmapheresis in thyrotoxic patients.</article-title>
            <source>Endocrine</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>144</fpage>
            <page-range>144-148</page-range>
            <pub-id pub-id-type="pmid">29968224</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
